Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Young hematologists and medical oncologists in focus

Young hematologists and medical oncologists in focus editorial memo (2020) 13:9–10 https://doi.org/10.1007/s12254-019-00559-y Barbara Kiesewetter for the “Young Hematologists & Oncologists Group Austria” (YHOGA) · Andreas Pircher for the “Young Hematologists & Oncologists Group Austria” (YHOGA) · Alexandra Boehm for the “Young Hematologists & Oncologists Group Austria” (YHOGA) Received: 4 December 2019 / Accepted: 10 December 2019 © Springer-Verlag GmbH Austria, part of Springer Nature 2020 In view of the constantly rising number of novel com- have potentially made the field of medical oncology pounds and the increasing complexity of available and hematology more attractive to young colleagues treatment modalities, the spectrum of professional due to an increasingly diversified work spectrum, pro- life in the field of oncology and malignant hema- fessional life in oncology is still characterized by a high tology has drastically changed in the last decade. work load accompanied with an enormous dual bur- While previously advanced malignant diseases were den of combining clinical work and scientific duties, mainly approached by “classical” cytotoxic agents often long work hours and finally emotional strain in with a clearly estimated toxicity profile, novel treat- dealing with vitally threatened patients. Furthermore, ments address often very specific targets in the cancer given the lack of comprehensive support groups and http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png memo - Magazine of European Medical Oncology Springer Journals

Young hematologists and medical oncologists in focus

Loading next page...
 
/lp/springer-journals/young-hematologists-and-medical-oncologists-in-focus-QxIeh11PuR
Publisher
Springer Journals
Copyright
Copyright © Springer-Verlag GmbH Austria, part of Springer Nature 2020
ISSN
1865-5041
eISSN
1865-5076
DOI
10.1007/s12254-019-00559-y
Publisher site
See Article on Publisher Site

Abstract

editorial memo (2020) 13:9–10 https://doi.org/10.1007/s12254-019-00559-y Barbara Kiesewetter for the “Young Hematologists & Oncologists Group Austria” (YHOGA) · Andreas Pircher for the “Young Hematologists & Oncologists Group Austria” (YHOGA) · Alexandra Boehm for the “Young Hematologists & Oncologists Group Austria” (YHOGA) Received: 4 December 2019 / Accepted: 10 December 2019 © Springer-Verlag GmbH Austria, part of Springer Nature 2020 In view of the constantly rising number of novel com- have potentially made the field of medical oncology pounds and the increasing complexity of available and hematology more attractive to young colleagues treatment modalities, the spectrum of professional due to an increasingly diversified work spectrum, pro- life in the field of oncology and malignant hema- fessional life in oncology is still characterized by a high tology has drastically changed in the last decade. work load accompanied with an enormous dual bur- While previously advanced malignant diseases were den of combining clinical work and scientific duties, mainly approached by “classical” cytotoxic agents often long work hours and finally emotional strain in with a clearly estimated toxicity profile, novel treat- dealing with vitally threatened patients. Furthermore, ments address often very specific targets in the cancer given the lack of comprehensive support groups and

Journal

memo - Magazine of European Medical OncologySpringer Journals

Published: Mar 3, 2020

There are no references for this article.